ECSTACY: A Review of MDMA and MDA

1987/12/01 by Robert P. Climko, Herbert Roehrich, Donald R. Sweeney +1 · 2 citations
Psychology · Neuroscience · Pharmacology, Toxicology and Pharmaceutics · #Psychedelics and Drug Studies #Neurotransmitter Receptor Influence on Behavior #Forensic Toxicology and Drug Analysis

paper · doi:10.2190/dcrp-u22m-aumd-d84h

openalex publication_date 1987/12/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30

Abstract

The Drug Enforcement Administration classified the drug methylenedioxymethamphetamine, MDMA, also known as Ecstacy, as a Schedule I controlled substance on July 1, 1985. The controversy surrounding the classification of MDMA is related to the question of its efficacy as an adjunct to psychotherapy and the larger issue of how to regulate the production and use of designer drugs. The authors review the literature on MDMA and its predecessor, MDA, a substance that differs from MDMA by one methyl group.

Citations

• Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals

Cited by

• An Exploration of the History and Controversies Surrounding MDMA and MDA
• MDMA [wikipedia]